Mirati Therapeutics Inc. News
Moderna, six flags, chevron and more: 'mad money' lightning round
A roundup of Jim Cramer's thoughts on stocks of interest to Mad Money viewers.
We're in Bizarro Land: Cramer's 'Mad Money' Recap (Wednesday 6/5/19)
Investors should consider recession-proof names in the current environment, Jim Cramer says.
Mirati Shares Fall After Cancer Trial Progress Report
Shares of Mirati Therapeutics fell Monday after the drug developer released a progress report of an early stage clinical trial of its lung cancer drug used in conjunction with a Bristol-Myers Squibb Co. medication.
Home Depot, Lowe's, The Blackstone Group: 'Mad Money' Lightning Round
Jim Cramer highlights Home Depot, Lowe's, The Blackstone Group, Capital Senior Living, Cypress Semiconductor.
Fundamentals Drive This Rally: Cramer's 'Mad Money' Recap
Jim Cramer says don't be too quick to ascribe today's gains just to tax reform. This rally was roaring well before that. Instead, credit Cisco and Wal-Mart Stores.
Mirati Skyrockets On Positive Data - Biotech Movers
The San Diego firm is scheduled to present positive preliminary data for two clinical studies of sitravatinib in non-small cell lung cancer at a symposium in Chicago on Friday.
A New Take on the Big Mac (May Be) Headed to U.S. McDonald's Menus
This is very different than the Big Mac you know and love.
We're Enduring 'Housing Recession,' Homebuilders' Economist Says
The builder confidence index breached the break-even measure of 50 in August for the first time since May 2020.